Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches
Authors
Keywords
-
Journal
JOURNAL OF PSYCHOPHARMACOLOGY
Volume -, Issue -, Pages 026988112199182
Publisher
SAGE Publications
Online
2021-02-21
DOI
10.1177/0269881121991822
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding
- (2020) Martin Korsbak Madsen et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis
- (2020) Simon B. Goldberg et al. PSYCHIATRY RESEARCH
- Emotions and brain function are altered up to one month after a single high dose of psilocybin
- (2020) Frederick S. Barrett et al. Scientific Reports
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
- (2018) Leor Roseman et al. Frontiers in Pharmacology
- Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature
- (2018) Timothy I. Michaels et al. BMC Psychiatry
- Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition
- (2018) Frederick S. Barrett et al. PSYCHOPHARMACOLOGY
- Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors
- (2017) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences
- (2017) Theresa M. Carbonaro et al. PSYCHOPHARMACOLOGY
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
- (2017) R. L. Carhart-Harris et al. PSYCHOPHARMACOLOGY
- Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
- (2017) Robin L Carhart-Harris et al. Scientific Reports
- Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
- (2016) Theresa M Carbonaro et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms
- (2016) Frederick S Barrett et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology
- (2016) Ido Hartogsohn JOURNAL OF PSYCHOPHARMACOLOGY
- Long-term follow-up of psilocybin-facilitated smoking cessation
- (2016) Matthew W. Johnson et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
- (2015) Frederick S Barrett et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
- (2015) Michael P Bogenschutz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- lavaan: AnRPackage for Structural Equation Modeling
- (2015) Yves Rosseel Journal of Statistical Software
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
- (2014) Matthew W Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Bioethics in popular science: evaluating the media impact of The Immortal Life of Henrietta Lacks on the biobank debate
- (2013) Matthew C Nisbet et al. BMC Medical Ethics
- Prediction of Psilocybin Response in Healthy Volunteers
- (2012) Erich Studerus et al. PLoS One
- Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
- (2011) Katherine A MacLean et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
- (2011) Roland R. Griffiths et al. PSYCHOPHARMACOLOGY
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
- (2010) Charles S. Grob et al. ARCHIVES OF GENERAL PSYCHIATRY
- Brain serotonin 2A receptor binding: Relations to body mass index, tobacco and alcohol use
- (2009) D. Erritzoe et al. NEUROIMAGE
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
- (2008) RR Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started